Associate Director, Thought Leader Liaison - Northeast/New England (NY, MA, RI, VT, CT, NH, ME, Northern NJ)

BS/BA or equivalent required preferably in Marketing, Science, Business Administration or other similar degree; an MBA or other advanced degree preferred.

Minimum 8+ years pharmaceutical sales and/or marketing experience

Hematology/Oncology experience is required

Strong scientific acumen and business acumen, with the ability to use knowledge of the industry and marketplace to identify long-term benefits for our customers.

Excellent communication and interpersonal skills to build relationships with KOLs

Analytical skills to evaluate campaign performance and identify trends

PharmaEssentia USA strives every day to improve the lives of patients as well as our employees. As a valued member of PharmaEssentia USA, you will enjoy the following benefits:

Comprehensive medical coverage

Dental and vision coverage

Generous paid time-off

401(k) retirement plan with competitive company match

Medical & Dependent Care Flexible Spending Account

The expected base salary range for this position is $185,000 to $215,000. Salary offers are based on a wide range of factors including relevant skills, training, experience, education and geographical location. Market and organizational factors are also considered. In addition to base salary and a competitive benefits package, successful candidates are eligible for short-term and long-term incentives.

Benefits of working with our team:

PharmaEssentia USA strives every day to improve the lives of patients as well as our employees. As a valued member of PharmaEssentia USA, you will enjoy the following benefits:

Comprehensive medical coverage

Dental and vision coverage

Generous paid time-off

It’s not often you get the chance to make a real impact on the lives of others, while expanding your own possibilities. You’ll find that rare opportunity at PharmaEssentia. Join us, and let’s transform lives, together.

PharmaEssentia Corporation is a rapidly growing biopharmaceutical innovator. We are leveraging deep expertise and proven scientific principles to deliver effective new biologics for challenging diseases in the areas of hematology and oncology, with one product approved and a diversifying pipeline. We believe in the potential to improve both health and quality of life for patients with limited options today through the combination of rigorous research and innovative thinking. Founded in 2003 by a team of Taiwanese-American executives and renowned scientists from U.S. biotechnology and pharmaceutical companies, today we are listed on the Taiwan Stock Exchange (TWSE: 6446) and are expanding our global presence with operations in the U.S., Japan, Singapore, South Korea, and China, along with a world-class biologics production facility in Taichung.